Who is sponsoring NCT03480984?

NCT03480984 is sponsored by Mayo Clinic.

What condition does NCT03480984 study?

NCT03480984 studies Thoracic Diseases.

What drugs are being tested in NCT03480984?

Interventions: Programmed Intermittent Bolus, Continuous Infusion.

What is the status of NCT03480984?

NCT03480984 is currently COMPLETED.

Last reviewed 2020-04-01 · How we verify

Continuous Versus Intermittent Bolus Infusion of Paravertebral Blocks for Thoracic Surgery

NCT03480984 NA COMPLETED

The researchers are trying to determine pain medication consumption in the first 24 hours after surgery in patients given the standard continuous infusion of local anesthetic versus patients given the same total dose via programmed intermittent dosing. Both groups will receive the option of patient controlled pain medication as well as the same dose of pre-programmed pain medication. The only difference is the rate of administration: continuous vs. hourly intervals.

Details

Lead sponsor	Mayo Clinic
Phase	NA
Status	COMPLETED
Enrolment	50
Start date	Mon Feb 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jan 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Thoracic Diseases

Interventions

Programmed Intermittent Bolus
Continuous Infusion

Countries

United States